Why is Aurobindo Pharma falling/rising?

As of 14-Nov, Aurobindo Pharma Ltd. is experiencing a price increase, currently at 1,227.95, reflecting a rise of 19.1 or 1.58%. The stock has shown strong performance recently, gaining 9.35% over the past week and outperforming its sector by 1.21% today. It has been on a consecutive gain streak for the last five days, and it is trading above its 5-day, 20-day, 50-day, 100-day, and 200-day moving averages. Additionally, there has been a significant increase in investor participation, with delivery volume rising by 119.54% against the 5-day average. However, despite the recent gains, the stock has a negative return of -1.76% over the past year, and its profits have decreased by -6.8%.
In the broader market context, Aurobindo Pharma's short-term return of +9.35% over the past week significantly outpaces the Sensex's return of +1.62% during the same period. While the stock has high institutional holdings at 41.81%, indicating strong investor confidence, it is trading at a premium compared to its peers' average historical valuations. The company maintains a low debt-to-equity ratio and a fair valuation, but the recent profit decline may raise concerns among investors. Overall, the stock's recent upward movement is supported by positive short-term performance and increased trading activity, despite longer-term challenges.